KARIN CLARY: Open Payments
NPI 1053307397 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,929 in 106 payments from 14 companies in 2025. Trend: 2023 $2,023 · 2024 $2,690 · 2025 $1,929
Food & beverage: $1,870Education: $58
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $651 |
| Teva Pharmaceuticals USA, Inc. | 26 | $476 |
| PFIZER INC. | 13 | $172 |
| Lundbeck LLC | 4 | $103 |
| Boston Scientific Corporation | 3 | $87 |
| Collegium Pharmaceutical, Inc. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Alkermes, Inc. | 2 | $52 |
| Axsome Therapeutics, Inc. | 2 | $42 |
Products named: AUSTEDO XR, QULIPTA, UBRELVY, NURTEC ODT, VRAYLAR, VYEPTI, REXULTI, Belbuca.
Industry payments across IN — which companies pay providers there.
